                         SEQUENCE LISTING

<110>  St. Jude Childrens Research Hospital
       Thomas, Paul
       Crawford, Jeremy
       Kirk, Allison
       Zamora, Anthony
 
<120>  T-Cell Receptor for Treating Fibrolamellar Hepatocellular 
       Carcinoma

<130>  SJ0081WO

<150>  62/864,539
<151>  2019-06-21

<160>  25    

<170>  PatentIn version 3.5

<210>  1
<211>  406
<212>  PRT
<213>  Homo sapiens

<400>  1

Met Gly Lys Asp Tyr Tyr Gln Thr Leu Gly Leu Ala Arg Gly Ala Ser 
1               5                   10                  15      


Asp Glu Glu Ile Lys Arg Ala Tyr Arg Arg Gln Ala Leu Arg Tyr His 
            20                  25                  30          


Pro Asp Lys Asn Lys Glu Pro Gly Ala Glu Glu Lys Phe Lys Glu Ile 
        35                  40                  45              


Ala Glu Ala Tyr Asp Val Leu Ser Asp Pro Arg Lys Arg Glu Ile Phe 
    50                  55                  60                  


Asp Arg Tyr Gly Glu Glu Val Lys Glu Phe Leu Ala Lys Ala Lys Glu 
65                  70                  75                  80  


Asp Phe Leu Lys Lys Trp Glu Ser Pro Ala Gln Asn Thr Ala His Leu 
                85                  90                  95      


Asp Gln Phe Glu Arg Ile Lys Thr Leu Gly Thr Gly Ser Phe Gly Arg 
            100                 105                 110         


Val Met Leu Val Lys His Lys Glu Thr Gly Asn His Tyr Ala Met Lys 
        115                 120                 125             


Ile Leu Asp Lys Gln Lys Val Val Lys Leu Lys Gln Ile Glu His Thr 
    130                 135                 140                 


Leu Asn Glu Lys Arg Ile Leu Gln Ala Val Asn Phe Pro Phe Leu Val 
145                 150                 155                 160 


Lys Leu Glu Phe Ser Phe Lys Asp Asn Ser Asn Leu Tyr Met Val Met 
                165                 170                 175     


Glu Tyr Val Pro Gly Gly Glu Met Phe Ser His Leu Arg Arg Ile Gly 
            180                 185                 190         


Arg Phe Ser Glu Pro His Ala Arg Phe Tyr Ala Ala Gln Ile Val Leu 
        195                 200                 205             


Thr Phe Glu Tyr Leu His Ser Leu Asp Leu Ile Tyr Arg Asp Leu Lys 
    210                 215                 220                 


Pro Glu Asn Leu Leu Ile Asp Gln Gln Gly Tyr Ile Gln Val Thr Asp 
225                 230                 235                 240 


Phe Gly Phe Ala Lys Arg Val Lys Gly Arg Thr Trp Thr Leu Cys Gly 
                245                 250                 255     


Thr Pro Glu Tyr Leu Ala Pro Glu Ile Ile Leu Ser Lys Gly Tyr Asn 
            260                 265                 270         


Lys Ala Val Asp Trp Trp Ala Leu Gly Val Leu Ile Tyr Glu Met Ala 
        275                 280                 285             


Ala Gly Tyr Pro Pro Phe Phe Ala Asp Gln Pro Ile Gln Ile Tyr Glu 
    290                 295                 300                 


Lys Ile Val Ser Gly Lys Val Arg Phe Pro Ser His Phe Ser Ser Asp 
305                 310                 315                 320 


Leu Lys Asp Leu Leu Arg Asn Leu Leu Gln Val Asp Leu Thr Lys Arg 
                325                 330                 335     


Phe Gly Asn Leu Lys Asn Gly Val Asn Asp Ile Lys Asn His Lys Trp 
            340                 345                 350         


Phe Ala Thr Thr Asp Trp Ile Ala Ile Tyr Gln Arg Lys Val Glu Ala 
        355                 360                 365             


Pro Phe Ile Pro Lys Phe Lys Gly Pro Gly Asp Thr Ser Asn Phe Asp 
    370                 375                 380                 


Asp Tyr Glu Glu Glu Glu Ile Arg Val Ser Ile Asn Glu Lys Cys Gly 
385                 390                 395                 400 


Lys Glu Phe Ser Glu Phe 
                405     


<210>  2
<211>  10
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  2

Glu Ile Phe Asp Arg Tyr Gly Glu Glu Val 
1               5                   10  


<210>  3
<211>  15
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  3

Cys Ala Leu Asp Met Phe Ser Gly Gly Tyr Asn Lys Leu Ile Phe 
1               5                   10                  15  


<210>  4
<211>  16
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  4

Cys Ala Thr Ser Arg Val Lys Thr Ser Gly Gly Tyr Glu Gln Tyr Phe 
1               5                   10                  15      


<210>  5
<211>  21
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  5

Lys Leu Ser Gly Ser Ala Ser Ala Pro Lys Leu Glu Glu Gly Glu Phe 
1               5                   10                  15      


Ser Glu Ala Arg Val 
            20      


<210>  6
<211>  27
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  6

Arg Ala Lys Arg Ser Gly Ser Gly Ala Thr Asn Phe Ser Leu Leu Lys 
1               5                   10                  15      


Gln Ala Gly Asp Val Glu Glu Asn Pro Gly Pro 
            20                  25          


<210>  7
<211>  16
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  7

Gly Ser Ala Asp Asp Ala Lys Lys Asp Ala Ala Lys Lys Asp Gly Lys 
1               5                   10                  15      


<210>  8
<211>  18
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  8

Cys Ala Leu Ser Glu Ala Glu Asp Ser Gly Gly Ser Asn Tyr Lys Leu 
1               5                   10                  15      


Thr Phe 
        


<210>  9
<211>  14
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  9

Cys Ala Glu Gly Leu Leu Ser Gly Asn Thr Pro Leu Val Phe 
1               5                   10                  


<210>  10
<211>  12
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  10

Cys Ala Val Asn Ile Leu Gly Asn Lys Leu Val Phe 
1               5                   10          


<210>  11
<211>  13
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  11

Cys Ala Val Ile Met Asp Ser Asn Tyr Gln Leu Ile Trp 
1               5                   10              


<210>  12
<211>  15
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  12

Cys Ala Ser Leu Gly Val Thr Gly Gly Gly Asn Lys Leu Thr Phe 
1               5                   10                  15  


<210>  13
<211>  13
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  13

Cys Ala Ala His Thr Gly Thr Ala Ser Lys Leu Thr Phe 
1               5                   10              


<210>  14
<211>  16
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  14

Cys Ala Val Ser Asp Asp Tyr Gly Gly Ser Gln Gly Asn Leu Ile Phe 
1               5                   10                  15      


<210>  15
<211>  16
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  15

Cys Ala Val Ser Arg Arg Pro Gly Gly Gly Asn Thr Pro Leu Val Phe 
1               5                   10                  15      


<210>  16
<211>  11
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  16

Cys Ala Val Pro Gly Asn Asn Lys Phe Tyr Phe 
1               5                   10      


<210>  17
<211>  14
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  17

Cys Ala Ser Ser Phe Leu Gly Ser Thr Asp Thr Gln Tyr Phe 
1               5                   10                  


<210>  18
<211>  15
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  18

Cys Ala Ser Ser Pro Gly Gln Gly Ser Arg Thr Glu Ala Phe Phe 
1               5                   10                  15  


<210>  19
<211>  16
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  19

Cys Ala Ser Ser Gln Glu Gly Gly Arg Leu Val Gly Thr Gln Tyr Phe 
1               5                   10                  15      


<210>  20
<211>  17
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  20

Cys Ala Ser Ser Leu Ser Leu Gly Gly Arg Gly Pro Asp Thr Gln Tyr 
1               5                   10                  15      


Phe 
    


<210>  21
<211>  14
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  21

Cys Ala Ser Ser Gln Asp Gly Ala Gly Gln Gly Tyr Thr Phe 
1               5                   10                  


<210>  22
<211>  14
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  22

Cys Ala Ser Asn Pro Leu Gly Gly Asn Gln Pro Gln His Phe 
1               5                   10                  


<210>  23
<211>  15
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  23

Cys Ala Ser Ser Gln Glu Val Arg Met Asn Thr Glu Ala Phe Phe 
1               5                   10                  15  


<210>  24
<211>  15
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  24

Cys Ser Ala Lys Thr Thr Gly Glu Val Pro Tyr Glu Gln Tyr Phe 
1               5                   10                  15  


<210>  25
<211>  19
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  25

Cys Ala Ser Ser Ala Asn Pro Thr Asp Pro Val Ile Leu Arg Tyr Gly 
1               5                   10                  15      


Tyr Thr Phe 
            


